Testing effectiveness (Phase 2)Study completedNCT01822093
What this trial is testing
Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT
Who this might be right for
ADV Infection Post Allo-HSCT
Cell Medica Ltd 8
Showing 2 of 2 results